Evidence map›Paper›PMID 37811811›Full record

ArticleImmunology and cell biology2024

Molecular insights into the HLA-B35 molecules' classification associated with HIV control.

Christian A Lobos, Demetra Sm Chatzileontiadou, Bonin Sok, Coral-Ann Almedia, Hanim Halim, Lloyd D'Orsogna, Stephanie Gras

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Immunology and cell biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Christian A LobosDepartment of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC, Australia.
Demetra Sm ChatzileontiadouDepartment of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC, Australia.
Bonin SokDepartment of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC, Australia.
Coral-Ann AlmediaDepartment of Clinical Immunology and PathWest, Fiona Stanley Hospital, Perth, WA, Australia.
Hanim HalimDepartment of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia.
Lloyd D'OrsognaDepartment of Clinical Immunology and PathWest, Fiona Stanley Hospital, Perth, WA, Australia.
Stephanie GrasDepartment of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC, Australia.ORCID 0000-0001-7416-038X
La Trobe University · AUThe University of Western Australia · AUMonash University · AU

Funding

Australian Institute of Nuclear Science and EngineeringNational Health and Medical Research Council 1159272
6 · The paper itself

Abstract

Human leukocyte antigen (HLA) class I molecules have been shown to influence the immune response to HIV infection and acquired immunodeficiency syndrome progression. Polymorphisms within the HLA-B35 molecules divide the family into two groups, namely, Px and PY. The Px group is associated with deleterious effects and accelerated disease progression in HIV

Indexed as

HIV-1HIV InfectionsHLA-B35 AntigenHLA-B AntigensHumansPeptidesHLA-B35 AntigenHLA-B AntigensPeptidesCD8+ T cellHIVHLAimmune responsepeptide presentation

Identifiers

PMID37811811
PMCPMC10952751
OpenAlexW4387440851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.